Literature DB >> 21800288

Family history of cancer and risk of sporadic differentiated thyroid carcinoma.

Li Xu1, Guojun Li, Qingyi Wei, Adel K El-Naggar, Erich M Sturgis.   

Abstract

BACKGROUND: Thyroid cancer incidence in the United States, particularly in women, has increased dramatically since the 1980s. Although the causes of thyroid cancer in most patients remain largely unknown, evidence suggests the existence of an inherited predisposition to development of differentiated thyroid carcinoma (DTC). Therefore, the authors explored the association between sporadic DTC and family history of cancer.
METHODS: In a retrospective hospital-based case-control study of prospectively recruited subjects who completed the study questionnaire upon enrollment, unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) as estimates of the DTC risk associated with first-degree family history of cancer.
RESULTS: The study included 288 patients with sporadic DTC and 591 cancer-free controls. Family history of thyroid cancer in first-degree relatives was associated with increased DTC risk (adjusted OR, 4.1; 95% CI, 1.7-9.9). All DTC cases in patients with a first-degree family history of thyroid cancer were cases of papillary thyroid carcinoma (PTC) (adjusted OR, 4.6; 95% CI, 1.9-11.1). Notably, the risk of PTC was highest in subjects with a family history of thyroid cancer in siblings (OR, 7.4; 95% CI, 1.8-30.4). In addition, multifocal primary tumor was more common among PTC patients with first-degree family history of thyroid cancer than among PTC patients with no first-degree family history of thyroid cancer (68.8% vs 35.5%, P = .01).
CONCLUSIONS: The study suggests that family history of thyroid cancer in first-degree relatives, particularly in siblings, is associated with an increased risk of sporadic PTC.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21800288      PMCID: PMC3208119          DOI: 10.1002/cncr.26398

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

1.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

2.  Malignant tumors in families of thyroid cancer patients.

Authors:  H D Vlajinac; B J Adanja; V R Zivaljević; R R Janković; R R Dzodić; D D Jovanović
Journal:  Acta Oncol       Date:  1997       Impact factor: 4.089

3.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.

Authors:  Tang Ho; Guojun Li; Chong Zhao; Qingyi Wei; Erich M Sturgis
Journal:  Laryngoscope       Date:  2005-06       Impact factor: 3.325

Review 6.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

7.  Lifestyle and other risk factors for thyroid cancer in Los Angeles County females.

Authors:  Wendy J Mack; Susan Preston-Martin; Leslie Bernstein; Dajun Qian
Journal:  Ann Epidemiol       Date:  2002-08       Impact factor: 3.797

8.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

9.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Family history of benign thyroid disease and cancer and risk of thyroid cancer.

Authors:  A Memon; A Berrington De González; Y Luqmani; A Suresh
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

View more
  15 in total

1.  Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.

Authors:  Alice J Sigurdson; Alina V Brenner; James A Roach; Lilia Goudeva; Jörg A Müller; Kai Nerlich; Christoph Reiners; Robert Schwab; Liliane Pfeiffer; Melanie Waldenberger; Melissa Braganza; Li Xu; Erich M Sturgis; Meredith Yeager; Stephen J Chanock; Ruth M Pfeiffer; Michael Abend; Matthias Port
Journal:  Carcinogenesis       Date:  2016-04-28       Impact factor: 4.944

2.  Incidental finding of papillary thyroid carcinoma on CT examination of mandibular lesion: Case report.

Authors:  Irfan Sugianto; Yoshinobu Yanagi; Hidenobu Konouchi; Miki Hisatomi; Shunsuke Okada; Babatunde O Bamgbose; Junichi Asaumi
Journal:  Mol Clin Oncol       Date:  2017-11-02

3.  Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective.

Authors:  Stephanie Cham; Kyle Zanocco; Cord Sturgeon; Michael W Yeh; Avital Harari
Journal:  Thyroid       Date:  2014-03-21       Impact factor: 6.568

Review 4.  Geographic influences in the global rise of thyroid cancer.

Authors:  Jina Kim; Jessica E Gosnell; Sanziana A Roman
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

5.  Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients.

Authors:  Yulu Gu; Xiaoli Liu; Yaqin Yu; Jieping Shi; Lizhe Ai; Hui Sun; Joseph Sam Kanu; Chong Wang; Yawen Liu
Journal:  Int J Endocrinol       Date:  2014-10-16       Impact factor: 3.257

Review 6.  Association of rs6983267 Polymorphism and Thyroid Cancer Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Jingdong Li; Xiaofei Wang; Jiahong Dong
Journal:  Med Sci Monit       Date:  2016-06-02

7.  Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.

Authors:  Alina V Brenner; Gila Neta; Erich M Sturgis; Ruth M Pfeiffer; Amy Hutchinson; Meredith Yeager; Li Xu; Cindy Zhou; William Wheeler; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

8.  Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.

Authors:  Huiling He; Wei Li; Dayong Wu; Rebecca Nagy; Sandya Liyanarachchi; Keiko Akagi; Jaroslaw Jendrzejewski; Hong Jiao; Kevin Hoag; Bernard Wen; Mukund Srinivas; Gavisha Waidyaratne; Rui Wang; Anna Wojcicka; Ilene R Lattimer; Elzbieta Stachlewska; Malgorzata Czetwertynska; Joanna Dlugosinska; Wojciech Gierlikowski; Rafal Ploski; Marek Krawczyk; Krystian Jazdzewski; Juha Kere; David E Symer; Victor Jin; Qianben Wang; Albert de la Chapelle
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

9.  Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer.

Authors:  Xin Zhang; Yulu Gu; Xiaoli Liu; Yaqin Yu; Jieping Shi; Qiong Yu; Hui Sun; Joseph Sam Kanu; Siyan Zhan; Yawen Liu
Journal:  Int J Endocrinol       Date:  2015-11-18       Impact factor: 3.257

10.  Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults.

Authors:  Seung-Kwon Myung; Chan Wha Lee; Jeonghee Lee; Jeongseon Kim; Hyeon Suk Kim
Journal:  Cancer Res Treat       Date:  2016-06-23       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.